Characterization of the pattern of ischemic stroke induced by artificial particle embolization in the rat brain

Biomaterials

Volumn 32, Issue 27, 2011, Pages 6381-6388

  Tsai, Ming Jun ^a   Tsai, Yi Hung ^b   Kuo, Yu Min ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Animal model; Chitin; Embolization; Microsphere

Indexed keywords

ANIMAL MODEL; BASAL GANGLIA; BLOOD FLOW; CEREBRAL INFARCTION; CEREBRAL VESSELS; COMMON CAROTID ARTERY; EMBOLIC STROKES; EMBOLIZATION; EXPANSION PROPERTIES; EXTERNAL CAROTID ARTERIES; INTRAVENOUS INJECTIONS; ISCHEMIC STROKES; MICRO-PARTICLES; MIDBRAIN; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); RAT BRAIN; SIZE GROUPS;

ANIMALS; BIOCOMPATIBILITY; BLENDING; BRAIN MODELS; CHITIN; ORGANIC POLYMERS; RATS;

BRAIN;

CHITIN; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; BASAL GANGLION; BIOCOMPATIBILITY; BRAIN BLOOD VESSEL; BRAIN CORTEX; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBELLUM; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; HEMISPHERE; HIPPOCAMPUS; HYDRATION; MALE; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; THALAMUS;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CHITIN; EMBOLISM; LACTIC ACID; MALE; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; PARTICLE SIZE; PARTICULATE MATTER; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; SEIZURES; STROKE;

ANIMALIA; RATTUS;

EID: 79960077483     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.051     Document Type: Article

References (22)

1. Harmsen P., Wilhelmsen L., Jacobsson A. Stroke incidence and mortality rates 1987 to 2006 related to secular trends of cardiovascular risk factors in Gothenburg, Sweden. Stroke 2009, 40:2691-2697.
2. Hoyte L., Kaur J., Buchan A.M. Lost in translation: taking neuroprotection from animal models to clinical trials. Exp Neurol 2004, 188:200-204.
3. Small D.L., Buchan A.M. Animal models. Br Med Bull 2000, 56:307-317.
4. Schneider A.T., Kissela B., Woo D., Kleindorfer D., Alwell K., Miller R., et al. Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites. Stroke 2004, 35:1552-1556.
5. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol 2003, 2:238-245.
6. Zivin J.A., Fisher M., Degirolami U., Hemenway C.C., Stashak J.A. Tissue plasminogen-activator reduces neurological damage after cerebral embolism. Science 1985, 230:1289-1292.
7. Carmichael S.T. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2005, 2:396-409.
8. Langer R., Folkman J. Polymers for the sustained release of proteins and other macromolecules. Nature 1976, 263:797-800.
9. Cao X., Schoichet M.S. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 1999, 20:329-339.
10. Sturesson C., Carlfors J. Incorporation of protein in PLG-microspheres with retention of bioactivity. J Control Release 2000, 67:171-178.
11. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21:2475-2490.
12. Eliaz R.E., Kost J. Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins. J Biomed Mater Res 2000, 50:388-396.
13. Muzzarelli R.A. Chitin and its derivatives: new trends of applied and research. Carbohydr Polym 1993, 3:52-57.
14. Mi F.L., Lin Y.M., Wu Y.B., Shyu S.S., Tsai Y.H. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior. Biomaterials 2002, 23:3257-3267.
15. Mi F.L., Shyu S.S., Lin Y.M., Wu Y.B., Peng C.K., Tsai Y.H. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials 2003, 24:5023-5036.
16. Miyake K., Takeo S., Kaijihara H. Sustained decrease in brain regional blood flow after microsphere embolism in rats. Stroke 1993, 24:415-420.
17. Beech J.S., Williams S.C., Campbell C.A., Bath P.M., Parsons A.A., Hunter A.J., et al. Further characterisation of a thromboembolic model of stroke in the rat. Brain Res 2001, 895:18-24.
18. Wang C.X., Todd K.G., Yang Y., Gordon T., Shuaib A. Patency of cerebral microvessels after focal embolic stroke in the rat. J Cereb Blood Flow Metab 2001, 21:413-421.
19. Zhang Z., Zhang R.L., Jiang Q., Raman S.B., Cantwell L., Chopp M. A new rat model of thrombotic focal cerebral ischemia. J Cereb Blood Flow Metab 1997, 17:123-135.
20. Gerriets T., Li F., Silva M.D., Meng X., Brevard M., Sotak C.H., et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods 2003, 122:201-211.
21. Mayzel-Oreg O., Omae T., Kazemi M., Li F.H., Fisher M., Cohen Y., et al. Microsphere-induced embolic stroke: an MRI study. Magnet Reson Med 2004, 51:1232-1238.
22. Gerriets T., Stolz E., Walberer M., Kaps M., Bachmann G., Fisher M. Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and strategies for its avoidance. Stroke 2003, 34:2234-2239.